Translational Academy

Translational Academy

Phacilitate and Cell and Gene Therapy Insights have teamed up to further support collaboration between academic and industry pioneers.

OPEN TO ALL WORLD STEM CELL SUMMIT ATTENDEES IN THE SHARED EXHIBIT HALL

The Translation Academy will highlight promising innovation and support its path to commercial success, focusing on the following themes:

  • Financing
  • Manufacturing
  • Regulatory
  • Reimbursement

Partners
bioinsights crm fresenius

 

Translation Academy Agenda

DAY 1 – TUESDAY, JANUARY 23
11:00 – 11:30 AM Morning coffee Beginning with the end in mind Dr Sven Kili, Vice President & Head of Cell & Gene Therapy Development, Rare Disease Unit, GlaxoSmithKline
Interviewed by: Elisa Manzotti, CEO & Founder, BioInsights
1:00 – 2:00 PM  

Lunch

Reimbursement Panel Discussion and Case Study – Reimbursement considerations for cell and gene therapies. Chair: Dr Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
Speaker: Dr Panos Kefalas, Head of Health Economics & Market Access, Cell and Gene Therapy Catapult
3:30 – 4:00 PM Afternoon tea Presentation Reserved
5:45 – 6:00 PM Evening reception Translational Pioneer Award BioInsights
6:00 – 7:45 PM   MaSTherCell global announcement

 

DAY 2 – WEDNESDAY, JANUARY 24
07:30 – 08:30 AM Breakfast / Registration Financing Panel Discussion and Case Study Chair: Dr Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
10:45 – 11:15 AM Morning coffee Utilizing Academia for translation of cell and gene therapies to the clinic Speaker: Dr David DiGiusto, Executive Director, Stanford University School of Medicine
1:00 – 2:00 PM Lunch Manufacturing Panel Discussion and Case Study: Cell and Gene Therapy Manufacturing Considerations. Chair: Dr Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
Speaker: Dr Aaron Dulgar-Tulloch, Director BridGE@CCRM, GE Healthcare
3:30 – 4:00 PM Afternoon tea Troubleshooting academia-industry tech transfer Dr Shashi Murthy, Professor, Northeastern University Interviewed by: Elisa Manzotti, CEO & Founder, BioInsights

 

DAY 3 – THURSDAY, JANUARY 25
07:30 – 08:30 AM Breakfast / Registration Regulatory Panel Discussion and Case Study Chair: Dr Michael May, President & CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
10:45 – 11:15 AM Morning coffee Interview: Regulatory insights for translational R&D Abla A. Creasey, PhD, Senior Director, Strategic Clinical, Regulatory & Infrastructure, California Institute for Regenerative Medicine (CIRM) Interviewed by: Elisa Manzotti, CEO & Founder, BioInsights
1:00 – 2:00 PM Lunch Cell & Gene Therapy World in summary: Highlights and trends from this year’s event Co-Moderators:
Sanjin Zvonic, PhD, Senior Director, Business Leader, Clinical & Commercial Manufacturing, PCT
Thomas Heathman, PhD, Business Leader, Technology Development, Manufacturing Development & GTP Services, PCT
David Smith, PhD, Biomedical Engineer, Innovation & Engineering, PCT